Elbasvir + Grazoprevir

Category: Hepatitis

Elbasvir + Grazoprevir Overview

Elbasvir/grazoprevir (trade name Zepatier /zptr/ ZEP--teer) is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor of hepatitis C virus's NS5A protein) and grazoprevir (an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and treatment-experienced patients.[1] Both elbasvir and grazoprevir were developed by Merck & Co. The US Food and Drug Administration (F...

Read more Elbasvir + Grazoprevir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Elbasvir/grazoprevir

Recent Elbasvir + Grazoprevir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Elbasvir + Grazoprevir
  • Tablet: 50mg + 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 January 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA